March 13, 2025 - 15:25

A recent study highlights a troubling connection between digital exclusion and mental health issues among older adults. Findings indicate that seniors who do not have access to the internet are at a considerably increased risk of experiencing depressive symptoms. This risk is particularly pronounced for those who also face challenges such as limited family support or lower income levels.
The research underscores the importance of internet connectivity as a vital resource for mental well-being in the aging population. With the rise of digital communication, older adults who are disconnected from online platforms may miss out on essential social interactions and support networks. This isolation can exacerbate feelings of loneliness and depression, further impacting their overall health.
As society continues to advance technologically, addressing the digital divide becomes crucial in promoting mental health among older adults. Ensuring equitable access to the internet could play a significant role in enhancing their quality of life and emotional resilience.
October 21, 2026 - 01:41
Ebola Case Confirmed in Abuja After Traveler Arrives From UgandaNigeria has confirmed an Ebola case in Abuja after a woman arriving from Uganda tested positive, making the country the latest in the region to report an infection as the outbreak continues to...
October 20, 2026 - 03:18
CIM Holds Annual Health and Benefits Fair for StaffThe California Institution for Men in Chino recently hosted its yearly Employee Health and Benefits Fair, giving staff a chance to learn about the resources available to them and their...
October 19, 2026 - 05:23
Health Officials Push for Flu Vaccinations as Early Cases Rise in Some StatesVirginia health officials are urging residents to get their flu shots as data from other parts of the country points to an early jump in infections this season. So far, only about 10 percent of...
October 18, 2026 - 21:18
VA Doctor Leads National Trial on GLP-1 Drugs for Alcohol Use DisorderA physician at the Philadelphia Veterans Affairs Medical Center is heading a nationwide clinical trial that will examine whether GLP-1 receptor agonists, the class of medications best known for...